Adient (ADNT) has been drawing attention after a stretch of mixed share performance, combining a one-month gain with a decline over the past three months, alongside improving annual revenue and net income figures on a reported basis.
See our latest analysis for Adient.
At a recent share price of $20.60, Adient has paired a 9.52% 30 day share price return with an 8.19% year to date gain. This contrasts with a 90 day share price decline of 8.57% and a 3 year total shareholder return loss of 50.81%, suggesting that recent momentum is rebuilding after a weaker longer term journey.
If Adient has you thinking about what else is moving in autos, it could be a good time to weigh up other auto manufacturers as potential ideas.
With Adient trading at $20.60 and indicators such as an intrinsic discount highlighting a substantial gap to some estimates, despite a recent 1-year total return of 23.65%, is this an undervalued turnaround story, or has the market already incorporated expectations for future growth?
With Adient last closing at $20.60 versus a narrative fair value of $22.95, the current setup centers on modest upside built on improving fundamentals.
The analysts have a consensus price target of $26.909 for Adient based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $64.0, and the most bearish reporting a price target of just $17.0.
Curious what kind of earnings swing, margin shift and P/E reset sit behind that fair value? The core narrative leans on a profitability turnaround and a lower multiple than many peers, all discounted at a relatively high required return. The full story connects slow revenue growth with a much sharper move in bottom line.
Result: Fair Value of $22.95 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, the narrative still hinges on Adient overcoming softer fiscal 2026 expectations and pressure on margins in regions like Europe and China, which could limit any rerating.
Find out about the key risks to this Adient narrative.
If this view does not quite fit how you see Adient, or you prefer to test the numbers yourself, you can build a custom thesis in just a few minutes and Do it your way
A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Adient.
If Adient has sharpened your focus, do not stop there, use the Simply Wall St Screener to spot more opportunities before they move without you.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ADNT.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com